CD163 and metastatic melanoma: As previously reported, in metastatic melanoma, a substantial number of CD163+ TAMs are present in metastatic melanoma and are activated by stromal factors, leading to an increase in serum levels of sCD163 as a result of proteolytic shedding (21–23).